Scientific Sessions 2024  /  Gene Therapy in the Cardiology Clinic: Ready for Prime Time?  /  So How Do We Determine the Right Strategy for the Right Patient?
Logo

American Heart Association

  2
  0

Final ID:

So How Do We Determine the Right Strategy for the Right Patient?

  • Watkins, Hugh  ( University of Oxford , Oxford , United Kingdom )
  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
    • Author Disclosures:
    Hugh Watkins: DO have relevant financial relationships ; Consultant:Cytokinetics:Active (exists now) ; Consultant:BridgeBio:Past (completed) ; Consultant:BioMarin:Active (exists now) | Christine Seidman: DO have relevant financial relationships ; Consultant:Maze:Active (exists now) ; Other (please indicate in the box next to the company name):Merck - Board of Directors:Active (exists now) ; Advisor:Burroughs Wellcome Fund:Active (exists now) ; Consultant:BridgeBio:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Gene Therapy in the Cardiology Clinic: Ready for Prime Time?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Gene Silencing: Targeting TTR in Amyloidosis as a Paradigm for Knocking Down Mutant Alleles

Alexander Kevin, Garcia-pavia Pablo

Gene Therapy in 2024: What Are the Options?

Helms Adam, Rosanno Joseph, Giacca Mauro

More abstracts from these authors:
Humoral profile of individuals with Chagas Cardiomyopathy

Venturini Da Silva Gabriela, Seidman Christine, Kula Tomasz, Bes Taniela, Shrock Ellen, Elledge Stephen, Gorham Joshua, Sabino Ester Cerdeira, Pereira Alexandre, Seidman Jonathan

Dysregulation of DSCAM and Sclerostin Signaling in Down Syndrome Associated Congenital Heart Disease and Other Phenotypes

Tang Vi, Zhang Qi, Morton Sarah, Mckean David, Narayan Priyanka, Layton Olivia, Sharma Ananya, Seidman Jonathan, Seidman Christine

You have to be authorized to contact abstract author. Please, Login
Not Available